This company has been marked as potentially delisted and may not be actively trading. NASDAQ:GHSI Guardion Health Sciences (GHSI) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisDividendTrendsBuy This Stock About Guardion Health Sciences Stock (NASDAQ:GHSI) Get GHSI alerts:Sign Up Key Stats Today's Range$3.22▼$3.2250-Day Range$3.22▼$3.5052-Week Range$3.04▼$18.00VolumeN/AAverage Volume105,261 shsMarket Capitalization$4.35 millionP/E Ratio0.66Dividend Yield155.28%Price TargetN/AConsensus RatingN/A Company Overview Guardion Health Sciences, Inc., a clinical nutrition company, develops and distributes clinically supported dietary supplements and medical foods in North America, Europe, and internationally. The company offers GlaucoCetin, a dietary supplement to support mitochondrial function with additional antioxidants to help reduce oxidative stress and increase blood flow throughout the body for enhanced eye support and ocular health; and Lumega-Z, a medical food that replenishes and restores the macular protective pigment. It also provides Viactiv Omega Boost Gel Bites, an omega-3 fish oil dietary supplement. The company distributes medical foods products through e-commerce website, guardionhealth.com. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in Houston, California. Read More Receive GHSI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Guardion Health Sciences and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GHSI Stock News HeadlinesGuardion Health Sciences Announces Declaration of Cash DistributionDecember 23, 2024 | globenewswire.comGuardion Health Sciences Announces Filing of Certificate of DissolutionOctober 30, 2024 | globenewswire.comThe REAL Reason Trump is Invading IranFor a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason. | Banyan Hill Publishing (Ad)Guardion Health Sciences Announces Delisting and New Interim CEOOctober 5, 2024 | finance.yahoo.comGuardion Health Sciences Inc (GHSI)October 3, 2024 | investing.comGuardion Health Sciences To Delist as It Goes Into Liquidation; Appoints Interim CEO, PresidentOctober 1, 2024 | marketwatch.comGuardion Health Sciences Announces Adoption of Plan of Dissolution and Liquidation; Appointment of Interim President and CEOOctober 1, 2024 | finance.yahoo.comWhy Guardion Health Sciences (GHSI) Stock Is Getting HammeredOctober 1, 2024 | msn.comSee More Headlines GHSI Stock Analysis - Frequently Asked Questions How were Guardion Health Sciences' earnings last quarter? Guardion Health Sciences, Inc. (NASDAQ:GHSI) released its quarterly earnings results on Monday, August, 12th. The company reported ($42.00) EPS for the quarter. The company had revenue of $0.26 million for the quarter. Guardion Health Sciences had a negative trailing twelve-month return on equity of 73.69% and a net margin of 22.79%. When did Guardion Health Sciences' stock split? Shares of Guardion Health Sciences reverse split on Sunday, January 8th 2023.The 1-50 reverse split was announced on Sunday, January 8th 2023. The number of shares owned by shareholders was adjusted after the market closes on Sunday, January 8th 2023. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split. When did Guardion Health Sciences IPO? Guardion Health Sciences (GHSI) raised $4 million in an initial public offering on Friday, April 5th 2019. The company issued 1,250,000 shares at $3.00-$4.00 per share. WallachBeth Capital and Westpark Capital acted as the underwriters for the IPO. What other stocks do shareholders of Guardion Health Sciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that Guardion Health Sciences investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Broadcom (AVGO), GE Aerospace (GE). Company Calendar Last Earnings8/12/2019Today5/15/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:GHSI CIK1642375 Webwww.guardionhealth.com Phone(800) 873-5141Fax858-630-5543Employees10Year Founded2009Profitability EPS (Trailing Twelve Months)$4.87 Trailing P/E Ratio0.66 Forward P/E RatioN/A P/E GrowthN/ANet Income$160 thousand Net Margins22.79% Pretax Margin-20.29% Return on Equity-73.69% Return on Assets-48.17% Debt Debt-to-Equity RatioN/A Current Ratio16.68 Quick Ratio16.59 Sales & Book Value Annual Sales$12.25 million Price / Sales0.35 Cash Flow$0.14 per share Price / Cash Flow23.15 Book Value$6.39 per share Price / Book0.50Miscellaneous Outstanding Shares1,350,000Free Float1,332,000Market Cap$4.35 million OptionableNot Optionable Beta0.73 Social Links The 10 Best AI Stocks to Own in 2026Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report This page (NASDAQ:GHSI) was last updated on 5/15/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | SponsoredYour book attachedYour Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Guardion Health Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Guardion Health Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
